Deep-pocketed investors have adopted a bullish approach towards IBM IBM, and it’s something market players shouldn’t ignore. Our tracking of public options records at
GoPro Sees Unusually Large Options Volume (NASDAQ:GPRO)
GoPro, Inc. (NASDAQ:GPRO – Get Free Report) was the target of unusually large options trading activity on Wednesday. Investors purchased 2,587 call options on
Dow Jones Today: Stock Futures Inch Higher as Earnings Reports Roll In; S&P 500 and Dow Nearing Record Highs
Stocks inched higher in early trading Thursday after two straight days of gains have taken major indexes back near all-time highs. The Dow Jones
Interval Funds: 6 Things to Know Before You Invest
Evaluate whether the product is right for you and the level of risk you’re willing to accept with your investments. Interval funds are closed-end
Trump tracker: US economy
$99 for your first year FT newspaper delivered Monday-Saturday, plus FT Digital Edition delivered to your device Monday-Saturday. What’s included Weekday Print Edition FT
Red Flag Warning – New Reasons Why You Should Re-Evaluate Your Tesla Stock Exposure In 2025 – Number Nine Is the Most Scary
Follow us today… Tesla stock is traded under the name TSLA on the NASDAQ. This public stock has had a long
MSTR, QCOM and ARM Forecast – Earnings Calls Move Tech Stocks on Thursday
Subscribe To Notifications Important DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by
Could 2025 Be a Repeat of 2022 for Big Tech?
Investors often love investing in tech stocks because of how much upside there can be in both the short term and long term. Companies
These 8 stocks could be the biggest losers as DeepSeek clouds the outlook for tech
DeepSeek’s AI model sent shockwaves through the stock market last week. The open-sourced AI model from China could impact the outlook for a number
Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics today
20:40 EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) today Maximize Your Portfolio with Data Driven Insights: Leverage the power